Skip to main content
. 2023 Dec 29;11(2):628–636. doi: 10.1002/ehf2.14647

Figure 2.

Figure 2

Annualized event rates of the primary endpoint of PARADIGM‐HF, DAPA‐HF, EMPEROR‐Reduced, and VICTORIA trials. Primary endpoint: PARADIGM‐HF [death from cardiovascular causes or hospitalization for heart failure (HF)], DAPA‐HF [cardiovascular death or worsening HF (hospitalization or an urgent visit resulting in intravenous therapy for HF)], EMPEROR‐Reduced (cardiovascular death or hospitalization for worsening HF), and VICTORIA (cardiovascular death or first hospitalization for HF). ARR, absolute risk reduction; CI, confidence interval; FU, follow‐up; HR, hazard ratio; NNT, number needed to treat; PY, patient‐years. Source: Figure performed with data from references 11, 34, 37, 42.